Share on StockTwits
 

Praxair (NYSE:PX) announced its earnings results on Wednesday. The company reported $1.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.04, Analyst Ratings News reports. The company had revenue of $3.00 billion for the quarter, compared to the consensus estimate of $3.05 billion.

Praxair (NYSE:PX) opened at 125.70 on Wednesday. Praxair has a one year low of $107.69 and a one year high of $134.23. The stock has a 50-day moving average of $129.0 and a 200-day moving average of $123.2. The company has a market cap of $37.001 billion and a price-to-earnings ratio of 22.22.

The company also recently announced a quarterly dividend, which is scheduled for Monday, March 17th. Investors of record on Friday, March 7th will be paid a dividend of 0.65 per share. This represents a $2.60 annualized dividend and a dividend yield of 2.07%.

Several analysts have recently commented on the stock. Analysts at UBS AG initiated coverage on shares of Praxair in a research note to investors on Monday, November 25th. They set a “neutral” rating and a $125.00 price target on the stock. On the ratings front, analysts at Barclays raised their price target on shares of Praxair from $125.00 to $135.00 in a research note to investors on Tuesday, November 5th. They now have an “equal weight” rating on the stock. Finally, analysts at Raymond James raised their price target on shares of Praxair from $135.00 to $145.00 in a research note to investors on Friday, November 1st. They now have a “strong-buy” rating on the stock. Six research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $135.77.

Praxair, Inc (NYSE:PX) is an industrial gases supplier.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.